Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Metro Healthcare BhdXKLS:0329 -6.12%57 3-Year ROIIC % is 31.40 as of Dec. 2025, which is 165% above its 10-year median of 11.86. GuruFocus rates XKLS:0329 with a GF Score™ of 57/100 and a GF Value™ of RM0.31 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 618 Healthcare Providers & Services companies, Metro Healthcare Bhd ranks better than 77.67% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Metro Healthcare Bhd's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 31.40%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Metro Healthcare Bhd's 3-Year ROIIC % or its related term are showing as below:
XKLS:0329's 3-Year ROIIC % is ranked better than 77.67% of 618
companies
in the Healthcare Providers & Services industry
Industry Median: 3.37
vs XKLS:0329: 31.40
Metro Healthcare Bhd (XKLS:0329) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Metro Healthcare Bhd 3-Year ROIIC % Related Terms
Metro Healthcare Bhd 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Metro Healthcare Bhd's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0329 vs HCA, THC, DVA: 3-Year ROIIC % Comparison
For the Medical Care Facilities subindustry, Metro Healthcare Bhd's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Metro Healthcare Bhd 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Metro Healthcare Bhd's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Metro Healthcare Bhd's 3-Year ROIIC % falls into.
Metro Healthcare Bhd's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 4.96797 (Dec. 2025) - 2.7586284 (Dec. 2022) )
/
( 37.375 (Dec. 2025) - 30.34 (Dec. 2022) )
=
2.2093416
/
7.035
=
31.40%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Metro Healthcare Bhd (XKLS:0329) has a 3-Year ROIIC % of 31.40 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Metro Healthcare Bhd and its competitors. This is 165% above median its historical median of 11.86. According to the industry distribution chart, Metro Healthcare Bhd ranks #138 out of 618 companies in the Healthcare Providers & Services industry, placing it in the top 22.3%.
Is Metro Healthcare Bhd's 3-Year ROIIC % too high?
Metro Healthcare Bhd's current 3-Year ROIIC % of 31.40 is 165% above median its 10-year median of 11.86. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.37. Metro Healthcare Bhd's value of 31.40 is 831.8% above this industry median. Based on the distribution chart, Metro Healthcare Bhd ranks #138 out of 618 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Metro Healthcare Bhd has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Metro Healthcare Bhd's 3-Year ROIIC % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Metro Healthcare Bhd ranks #138 out of 618 companies for 3-Year ROIIC %. This places Metro Healthcare Bhd in the top 22% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 3.37. Metro Healthcare Bhd's value of 31.40 is 831.8% above this benchmark. While the company's 10-year median is 11.86 vs. the industry median of 3.37, Metro Healthcare Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.37, based on 618 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Metro Healthcare Bhd's current 3-Year ROIIC % of 31.40 is 831.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Metro Healthcare Bhd and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Metro Healthcare Bhd's current 3-Year ROIIC % is 31.40, which is 165% above median its own 10-year median of 11.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metro Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, Metro Healthcare Bhd (XKLS:0329) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.31, compared to a current price of RM0.23 — trading 25.8% below its estimated fair value. The current 3-Year ROIIC % is 31.40, which is 165% above median its 10-year median of 11.86 and 831.8% above the Healthcare Providers & Services industry median of 3.37. Metro Healthcare Bhd's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Metro Healthcare Bhd (XKLS:0329), the current 3-Year ROIIC % is 31.40 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Metro Healthcare Bhd (XKLS:0329) Overvalued in 2026?
Based on GuruFocus' analysis, Metro Healthcare Bhd stock appears to be undervalued.
The current stock price of RM0.23 is trading 25.8% below its estimated GF Value™ of RM0.31.
GuruFocus considers Metro Healthcare Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0329:
3-Year ROIIC %: 31.40 (165% above median its 10-year median of 11.86)
GF Value™: RM0.31 vs. price of RM0.23 (25.8% below fair value)
Industry Position: 831.8% above the Healthcare Providers & Services median (#138 of 618)
No single metric tells the full story. See the XKLS:0329 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Metro Healthcare Bhd is engaged in the provision of women healthcare services. The company offers various services such as obstetrics, gynecology impatient services, and diagnostic medical imaging services. It also provides semen analysis, intracytoplasmic sperm injection, blastocyst culture, assisted hatching, frozen embryo transfer, preimplantation genetic screening, and infertility consultation services. The company serves patients in Malaysia. The firm's business segment includes O&G healthcare services, Complementary services, and Hospital services.
57GF Score
Get the complete analysis for XKLS:0329
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0329 has been successfully added to your 
